Should I buy or sell Cue Health stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLTH, but not buy additional shares or sell existing shares. View HLTH analyst ratings or view top-rated stocks .

What is Cue Health's stock price target for 2024?

2 brokers have issued 1 year price objectives for Cue Health's shares. Their HLTH share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 1,981.9% from the stock's current price. View analysts price targets for HLTH or view top-rated stocks among Wall Street analysts .

How have HLTH shares performed in 2024?

Cue Health's stock was trading at $0.1625 at the beginning of 2024. Since then, HLTH shares have decreased by 11.3% and is now trading at $0.1441. View the best growth stocks for 2024 here .

Are investors shorting Cue Health?

Cue Health saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 563,500 shares, a decrease of 22.9% from the March 15th total of 730,600 shares. Based on an average daily volume of 519,600 shares, the short-interest ratio is currently 1.1 days. Currently, 0.5% of the company's stock are sold short. View Cue Health's Short Interest .

When is Cue Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our HLTH earnings forecast .

How were Cue Health's earnings last quarter?

Cue Health Inc. (NASDAQ:HLTH) released its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.45) by $0.13. The business earned $18.80 million during the quarter, compared to the consensus estimate of $17.60 million. Cue Health had a negative trailing twelve-month return on equity of 67.82% and a negative net margin of 526.48%.

What guidance has Cue Health issued on next quarter's earnings?

Cue Health updated its first quarter 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $9.0 million-$11.0 million, compared to the consensus revenue estimate of $28.9 million.

When did Cue Health IPO?

Cue Health (HLTH) raised $200 million in an IPO on Friday, September 24th 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

How do I buy shares of Cue Health?

Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HLTH

Cue Health (HLTH) Stock Price, News & Analysis

→ Nvidia Has a BIG Problem — Here’s Who Benefits MOST (From Weiss Ratings) (Ad)

Free HLTH Stock Alerts

$0.14

0.00 (-1.80%)

(As of 02:51 PM ET)

Compare

Today's Range: $0.14
▼
$0.15
50-Day Range: $0.14
▼
$0.32
52-Week Range: $0.14
▼
$1.28

Volume: 241,191 shs
Average Volume: 927,948 shs
Market Capitalization: $22.51 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Get Cue Health alerts:

Cue Health MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 1,981.9% Upside
$3.00 Price Target
Short Interest: Healthy
0.52% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.13) to ($0.39) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

Medical Sector

384th out of 914 stocks

Analytical Instruments Industry

16th out of 27 stocks

3.0

Analyst's Opinion

Consensus Rating
Cue Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Cue Health has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.52% of the float of Cue Health has been sold short.
Short Interest Ratio / Days to Cover
Cue Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cue Health has recently decreased by 22.87%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Cue Health does not currently pay a dividend.
Dividend Growth
Cue Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLTH.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Cue Health this week, compared to 1 article on an average week.
Search Interest
2 people have searched for HLTH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Cue Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cue Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
12.50% of the stock of Cue Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
45.49% of the stock of Cue Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Cue Health are expected to grow in the coming year, from ($1.13) to ($0.39) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cue Health is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cue Health is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cue Health has a P/B Ratio of 0.09. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Weiss Ratings

This Little-Known Stock Controls the Future of AI

#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'

If You Missed Out On The AI Boom, Take These 3 Steps

About Cue Health Stock (NASDAQ:HLTH)

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

HLTH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HLTH Stock News Headlines

April 17, 2024 | americanbankingnews.com

Cue Health (NASDAQ:HLTH) Trading Down 3.5%

March 22, 2024 | markets.businessinsider.com

Cue Health’s Hold Rating Amidst Leadership Changes and FDA Setbacks

April 18, 2024 | Weiss Ratings (Ad)

Nvidia Has a BIG Problem — Here’s Who Benefits MOST

March 20, 2024 | finance.yahoo.com

Cue Health Announces Strategic Actions to Position Company for Next Stage

March 20, 2024 | businesswire.com

Cue Health Announces Strategic Actions to Position Company for Next Stage

March 18, 2024 | investorplace.com

3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter

March 16, 2024 | investing.com

BTIG downgrades Cue Health stock amid cash runway and FDA approval concerns

March 16, 2024 | seekingalpha.com

Cue Health, Inc. (HLTH) Q4 2023 Earnings Call Transcript

April 18, 2024 | Weiss Ratings (Ad)

Nvidia Has a BIG Problem — Here’s Who Benefits MOST

March 15, 2024 | finance.yahoo.com

Cue Health Inc. (NASDAQ:HLTH) Q4 2023 Earnings Call Transcript

March 15, 2024 | finance.yahoo.com

HLTH Mar 2024 2.500 put

March 14, 2024 | markets.businessinsider.com

Buy Rating Affirmed for Guardant Health Amid Strong Shield Test Prospects and Positive ECLIPSE Study Results

March 13, 2024 | benzinga.com

Cue Health: Q4 Earnings Insights

March 13, 2024 | businesswire.com

Cue Health Reports Fourth Quarter 2023 Financial Results

March 6, 2024 | finance.yahoo.com

HLTH Sep 2024 7.500 call

February 28, 2024 | finance.yahoo.com

Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results

February 23, 2024 | benzinga.com

Cue Health Stock (NASDAQ:HLTH) Insider Trades

February 20, 2024 | finance.yahoo.com

HLTH Sep 2024 2.500 call

February 16, 2024 | finance.yahoo.com

Cue Health Announces Appointment of Rishi Reddy to Board of Directors

February 16, 2024 | businesswire.com

Cue Health Announces Appointment of Rishi Reddy to Board of Directors

January 9, 2024 | morningstar.com

Cue Health Inc HLTH

January 3, 2024 | markets.businessinsider.com

BTIG Reaffirms Their Buy Rating on Cue Health (HLTH)

January 1, 2024 | benzinga.com

Cue Health Stock (NASDAQ:HLTH) Dividends: History, Yield and Dates

November 10, 2023 | msn.com

Cue Health GAAP EPS of -$0.31 beats by $0.16, revenue of $17.5M beats by $6.29M

November 10, 2023 | finance.yahoo.com

Cue Health Inc. (NASDAQ:HLTH) Not Doing Enough For Some Investors As Its Shares Slump 28%

November 9, 2023 | finance.yahoo.com

Cue Health Inc. (NASDAQ:HLTH) Q3 2023 Earnings Call Transcript

November 8, 2023 | benzinga.com

Cue Health: Q3 Earnings Insights

See More Headlines

Receive HLTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cue Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/13/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Analytical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:HLTH
CUSIP: N/A
CIK: 1628945
Web: www.cuehealth.com
Phone: 858-412-8151
Fax: N/A
Employees: 726
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $3.00
High Stock Price Target: $3.00
Low Stock Price Target: $3.00
Potential Upside/Downside: +1,855.7%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.44)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-373,460,000.00
Net Margins: -526.48%
Pretax Margin: -519.72%
Return on Equity: -67.82%
Return on Assets: -53.79%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.54
Quick Ratio: 2.22

Sales & Book Value

Annual Sales: $70.94 million
Price / Sales: 0.34
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.62 per share
Price / Book: 0.09

Miscellaneous

Outstanding Shares: 158,520,000
Free Float: 138,702,000
Market Cap: $24.32 million
Optionable: Optionable
Beta: 1.23

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Clint Sever (Age 39)
Co-Founder & CEO
Comp: $906.39k
Mr. Ayub K. Khattak (Age 39)
Co-Founder & Director
Comp: $1.06M
Mr. Christopher K. Achar (Age 38)
Chief Business Officer & Director
Mr. Aasim Javed (Age 40)
CFO, Treasurer & Principal Financial Officer
Mr. Randall E. Pollard (Age 52)
Controller & Principal Accounting Officer
Ms. Lorna Williams
Vice President of Investor Relations
Ms. Erica Palsis Esq. (Age 38)
General Counsel & Corporate Secretary
Ms. Eileen Sheil
Chief Communications Officer
Mr. Nitin Duggal
Chief Marketing Officer
Ms. Allison F. Blackwell (Age 59)
Chief Human Resources Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HLTH Stock Analysis - Frequently Asked Questions

Should I buy or sell Cue Health stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLTH, but not buy additional shares or sell existing shares.
View HLTH analyst ratings or view top-rated stocks.
What is Cue Health's stock price target for 2024?: 2 brokers have issued 1 year price objectives for Cue Health's shares. Their HLTH share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 1,981.9% from the stock's current price.
View analysts price targets for HLTH or view top-rated stocks among Wall Street analysts.
How have HLTH shares performed in 2024?: Cue Health's stock was trading at $0.1625 at the beginning of 2024. Since then, HLTH shares have decreased by 11.3% and is now trading at $0.1441.
View the best growth stocks for 2024 here.
Are investors shorting Cue Health?: Cue Health saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 563,500 shares, a decrease of 22.9% from the March 15th total of 730,600 shares. Based on an average daily volume of 519,600 shares, the short-interest ratio is currently 1.1 days. Currently, 0.5% of the company's stock are sold short.
View Cue Health's Short Interest.
When is Cue Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our HLTH earnings forecast.

How were Cue Health's earnings last quarter?: Cue Health Inc. (NASDAQ:HLTH) released its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.45) by $0.13. The business earned $18.80 million during the quarter, compared to the consensus estimate of $17.60 million. Cue Health had a negative trailing twelve-month return on equity of 67.82% and a negative net margin of 526.48%.
What guidance has Cue Health issued on next quarter's earnings?: Cue Health updated its first quarter 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $9.0 million-$11.0 million, compared to the consensus revenue estimate of $28.9 million.
When did Cue Health IPO?: Cue Health (HLTH) raised $200 million in an IPO on Friday, September 24th 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.
How do I buy shares of Cue Health?: Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HLTH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial